US Patent 7666844 Dry mouldable drug formulation
Patent 7666844 was granted and assigned to Novo Nordisk on February, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7666844 Dry mouldable drug formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
